Regarding lack of access to the Bridge Program, we want to clarify the following: Under federal law, Medicare Part D plans cannot cover medications prescribed for weight loss Medications that are FDA-approved for both weight loss and other indications may only be covered by Part D plans for non-weight loss indications. This Bridge Program is a trial of a way to address the particular problem of Part D restrictions on weight-loss prescriptions
Inflammopharmacology 14 , 214221
Additionally, glucose is redirected into the PPP, which supports cellular repair and regeneration by producing NADPH and nucleotide precursors, and by maintaining intracellular levels of glutathione, a key antioxidant (Scantlebery et al., 2021)
GLP-1s reduce appetite, which often means eating less overall
Foti et al
Lifestyle and diet are essential components of effective treatment with semaglutide and sertraline